DOPATREE
Preview
Open in TheBrain
DOPATREE
PRODUCTS
DRUGS AND BIOLOGICS-ALL (DRUG-DEVICE, BIOLOGIC-DEVICE COMBOS, COMBINATIONS, MEDICINES, THERAPEUTICS)
DRUGS AND BIOLOGICS / TYPES
OVER THE COUNTER DRUGS IN US-ALL (OTC, OVER-THE-COUNTER BEHIND-THE-COUNTER, BTC, NONPRESCRIPTION, NON-PRESCRIPTION, COMBINATION INGREDIENTS)
OVER THE COUNTER DRUGS IN US / RELATED
HUMAN FACTOR STUDY (STUDIES, MEDICATION ERRORS, HF, THRESHOLD ANALYSIS, USABILITY ENGINEERING, USER EXPERIENCE, FACTORS, HUMAN FACTORS VALIDATION)
HUMAN FACTOR STUDY / LAWS AND REGULATIONS / US
Parents
HUMAN FACTOR STUDY (STUDIES, MEDICATION ERRORS, HF, THRESHOLD ANALYSIS, USABILITY ENGINEERING, USER EXPERIENCE, FACTORS, HUMAN FACTORS VALIDATION)
Children
US FDA. DRAFT GUIDANCE. COMPARATIVE ANALYSES AND RELATED COMPARATIVE USE HUMAN FACTORS STUDIES FOR A DRUG-DEVICE COMBINATION PRODUCT SUBMITTED IN AN ANDA. JAN 2017.
US FDA. DRAFT GUIDANCE. CONTENT OF HUMAN FACTORS INFORMATION IN MEDICAL DEVICE MARKETING SUBMISSIONS. DEC 9, 2022.
US FDA. DRAFT GUIDANCE. CONTENTS OF A COMPLETE SUBMISSION FOR THRESHOLD ANALYSES AND HUMAN FACTORS SUBMISSIONS TO DRUG AND BIOOGIC APPLICATIONS. SEP 2018.
US FDA. DRAFT GUIDANCE. HUMAN FACTORS STUDIES AND RELATED CLINICAL STUDY CONSIDERATIONS IN COMBINATION PRODUCT DESIGN AND DEVELOPMENT. FEB 2016.
US FDA. DRAFT GUIDANCE. LIST OF HIGHEST PRIORITY DEVICES FOR HUMAN FACTORS REVIEW. FEB 3, 2016.
US FDA. GUIDANCE. APPLYING HUMAN FACTORS AND USABILITY ENGINEERING TO MEDICAL DEVICES. FEB 3, 2016.